HDAC9 and histiocytic sarcoma: Among them, 5 were histone deacetylase (HDAC) inhibitors, indicating that strategies to deactivate the HDAC pathway might be useful to promote infiltration of cytotoxic T cells into the microenvironment of HS tumors.